Adipic Acid

Adipic Acid

SCHEMBL347426

O=C(O)CCCCC(=O)O.OCCOCCOCC(O)CO

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC18A2SLC6A2SLC6A3

The experimentally established mechanism targets of Adipic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.43
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 2/20 0.41
GPR84 Q9NQS5 1/20 0.41
LMNA P02545 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
DUSP3 P51452 1/20 0.39
CAMK2A Q9UQM7 1/20 0.39
TSHR P16473 3/20 0.37
NFKB1 P19838 1/20 0.37
PMP22 Q01453 1/20 0.37
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.34
DGKA P23743 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adipic Acid SCHEMBL7743772 0.95 USP2 (0.47) USP2FFAR1FFAR4GPR84LMNA
Adipic Acid SCHEMBL8486335 0.89 FFAR1 (0.46) FFAR1FFAR4GPR84LMNAMEN1
SCHEMBL28203478 0.87 USP2 (0.56) USP2FFAR1FFAR4GPR84LMNA
SCHEMBL7134435 0.87 FFAR4 (0.49) FFAR1FFAR4GPR84LMNACAMK2A
SCHEMBL17782931 0.87 FFAR4 (0.49) FFAR1FFAR4GPR84LMNACAMK2A
SCHEMBL7142279 0.87 FFAR4 (0.49) FFAR1FFAR4GPR84LMNACAMK2A
SCHEMBL9649626 0.87 FFAR4 (0.49) FFAR1FFAR4GPR84LMNACAMK2A
Adipic Acid SCHEMBL6740995 0.86 USP2 (0.51) USP2FFAR1FFAR4GPR84LMNA
SCHEMBL6653958 0.86 USP2 (0.59) USP2FFAR1FFAR4GPR84LMNA
SCHEMBL7157613 0.86 USP2 (0.59) USP2FFAR1FFAR4GPR84LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113440422-A Matte eyeliner and preparation method thereof 上海联锴新材料有限公司 2021-09-28 CN claimed
US-10172783-B2 High UV protection alcohol-free anhydrous clear system L'OREAL (FR) 2019-01-08 US claimed
CN-103655313-B A kind of whitening skin and preserving moisture skin care suncream NOX-BELLCOW (ZHONGSHAN) NONWOVEN CHEMICAL LIMITED (CN) 2015-09-16 CN claimed
EP-1815844-B1 Photoprotecting compositions with reduced risk of skin sensitisation DERMATOLOGIQUES D URIAGE LAB (FR) 2015-04-29 EP claimed
CN-104546561-A Three-dimensional molding wax oil powder and preparation method thereof LIXIN BIOTECH COSMETIC SHANGHAI CO LTD 2015-04-29 CN claimed
US-20140205546-A1 NANOSCALE PARTICLE FORMULATIONS AND METHODS Annuary Healthcare, Inc. 2014-07-24 US claimed
CN-103876948-A Rana japonica oil collagen peptide moisturizing sun cream and preparation process thereof UNIV JILIN 2014-06-25 CN claimed
US-20140170089-A1 PHOTOPROTECTIVE EYE CREAM AND METHODS Taylor James, LLC (US) 2014-06-19 US claimed
CN-103655313-A Whitening, moisturizing, sun screening and skin caring cream NOX BELLCOW ZHONGSHAN NONWOVEN CHEMICAL LTD 2014-03-26 CN claimed
US-20130177504-A1 Nanoscale Particle Formulations and Methods Annuary Healthcare, Inc. (US) 2013-07-11 US claimed
US-20020110571-A1 Fiber-containing cosmetic composition KANJI MOHAMED (US) 2002-08-15 US claimed
WO-2002060403-A2 HIGH OIL CLEAR EMULSION WITH ELASTOMER COLGATE-PALMOLIVE COMPANY (US) 2002-08-08 WO claimed
US-6426062-B1 MIXTURE OF STARCH GRAFT POLYMER, SILICONE AND GELATION AGENT COLGATE-PALMOLIVE COMPANY 2002-07-30 US claimed
WO-2002049586-A2 FIBER-CONTAINING COSMETIC COMPOSITION L'OREAL SA (FR) 2002-06-27 WO claimed
US-6403069-B1 SILICONE, ANTIPERSPIRANT, SOLVENT AND EMULSIFIER COLGATE-PALMOLIVE COMPANY 2002-06-11 US claimed
WO-2002043490-A1 FOAMING INSECT REPELLENT COMPOSITIONS AVON PRODUCTS, INC. (US) 2002-06-06 WO claimed
EP-1208836-A2 Fiber-containing base composition for use with mascara L'OREAL S.A. (FR) 2002-05-29 EP claimed
US-6387357-B1 CYCLOMETHICONE OR DIMETHICONE CROSSPOLYMER OF A POLYSILOXANE AND AN ALPHA, OMEGA DIENE; A SILICONE COPOLYOL; A VOLATILE SILICONE; ANTIPERSPIRANT AND/OR DEODORANT WATER IN OIL EMULSION COLGATE-PALMOLIVE COMPANY 2002-05-14 US claimed
WO-2002034212-A2 HIGH OIL CLEAR EMULSION WITH DIENE ELASTOMER COLGATE-PALMOLIVE COMPANY (US) 2002-05-02 WO claimed
EP-0118876-B1 Shaped bodies of cellular polyurethane, method for their manufacture by thermoplastic deformation of polyester-polyurethane foam and their use BASF AG (DE) 1993-11-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140205546-A1 NANOSCALE PARTICLE FORMULATIONS AND METHODS CUTA, S100P, KRT18 USP2 1150/4885FFAR1 315/4885FFAR4 1041/4885
US-20130177504-A1 Nanoscale Particle Formulations and Methods CUTA, S100P, KRT18 USP2 1150/4885FFAR1 315/4885FFAR4 1041/4885
US-20140170089-A1 PHOTOPROTECTIVE EYE CREAM AND METHODS CUTA, MICA, CSTB USP2 1532/4885FFAR1 3363/4885FFAR4 3205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.